Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)

China · Delayed Price · Currency is CNY

28.72

+1.23 (4.47%)

Nov 2, 2026, 2:15 PM CST

Market Cap	13.11B -2.4%
Revenue (ttm)	5.89B -3.5%
Net Income	279.92M
EPS	0.60
Shares Out	456.64M
PE Ratio	47.49
Forward PE	28.79
Dividend	0.88 (3.06%)
Ex-Dividend Date	Feb 5, 2026

Volume	11,372,510
Open	27.46
Previous Close	27.49
Day's Range	26.49 - 28.85
52-Week Range	21.50 - 40.68
Beta	0.37
Analysts	Buy
Price Target	30.60 (+6.55%)
Earnings Date	Oct 29, 2026

About SHA:603882

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides medical health check-up, medical cold chain logistics, and other services, as well as sells diagnostic products. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2006

Employees 9,529

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603882

Full Company Profile

Financial Performance

In 2025, SHA:603882's revenue was 6.03 billion, a decrease of -16.12% compared to the previous year's 7.19 billion. Losses were -173.24 million, -54.56% less than in 2024.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 603882 stock is "Buy." The 12-month stock price target is ¥30.60, which is an increase of 6.55% from the latest price.

Price Target

¥30.60

(6.55% upside)

Analyst Consensus: Buy

Stock Forecasts